A

Ajinomoto Health & Nutrition North America

Process Support Specialist

Full-TimeDeadline 9/3/27
$75k/yr
Mid
Bachelor's, Associate's
Eddyville, IA, USA
In Person
Manufacturing & Process EngineeringProcess Engineering

About the job

Requirements
  • A two-year degree in bio-processing or a related field is required.
  • At least 2 years of experience in a manufacturing setting is required.
  • The role requires strong verbal and written communication skills.
  • The role requires scientific and technical proficiency.
  • Knowledge of amino acid production processes is required.
  • Knowledge of Good Manufacturing Practices and familiarity with standard operating procedures are required.
  • The ability to transfer technical knowledge to practical applications is required.
  • The ability to design laboratory experiments for commercial plant scale-up is required.
  • Knowledge of computers and electronic data processing is required.
  • Working knowledge of laboratory and analytical equipment is required.
  • The position requires safety awareness and adherence to safety, quality, environmental, state, federal, and company policies and guidelines.
  • The position requires the ability to sit or stand, repetitively use the hands and arms, and maintain eye-hand coordination for more than 6 hours per day.
  • The position requires walking, occasional lifting of up to 50 pounds, and occasional bending, overhead reaching, crouching, balancing, pushing, or pulling.
  • The position may require the ability to drive a car or truck.
Responsibilities
  • Research and provide plant support for the purification process.
  • Assist with developing processes to improve product yield and productivity and reduce manufacturing costs.
  • Assist manufacturing staff in solving production-system problems with minimal guidance.
  • Recommend process formulas and technologies to achieve cost effectiveness and quality.
  • Write experimental reports and summaries.
  • Apply scientific theory to develop new products and processes.
  • Design and scale processes, instruments, and equipment from laboratory development through pilot-plant and manufacturing stages using process and engineering calculations.
  • Research production-site issues and lead efforts to solve problems affecting stable operations.
  • Collect, analyze, and apply information from within and outside the plant and from previous technical history to solve problems.
  • Identify and plan activities to support stable operations and continuous improvement.
  • Support plant production technical targets, including productivity, yields, and variable-cost unit consumption.
  • Support investigations, corrective and preventive actions, and troubleshooting of process deviations.
  • Assist with preparing work instructions and standard operating procedures.
  • Communicate and document project and operations status for upper management.
  • Ensure preventive maintenance for laboratory equipment.
  • Assist with planning, prioritizing, and assigning work within the department.
  • Resolve problems and set deadlines to ensure timely completion of work.
  • Collaborate with other departments to accomplish tasks and goals.
  • Suggest and implement process-improvement, cost-reduction, and best-practice ideas.
  • Improve processing efficiency.
  • Complete 5S activities to keep the work area clean and organized.
  • Complete or assist with audits and follow up on findings until they are corrected.
  • Report identified hazards for correction.
  • Attend scheduled training sessions related to compliance initiatives.
  • Maintain ISO standards in all areas of departmental work.
Desired Qualifications
  • A four-year degree in an engineering or science-related field is preferred.

About the company

A

Ajinomoto Health & Nutrition North America

View

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • June 22, 2026 Syntax Bio collaboration expands StemFit into cell-therapy development.
  • February 11, 2025 LabCentral sponsorship improves access to biotech startups and founders.
  • June 4, 2025 Raleigh lab renovation supports larger API volumes and stricter quality control.

What critics are saying

  • Ajinomoto Foods North America’s March 2026 glass recall damaged North America brand trust.
  • Thermo Fisher, Merck, Lonza, and Cytiva crowd stem-cell media, squeezing pricing.
  • If StemFit stays niche, AHN remains dependent on low-volume specialty wins by 2027.

What makes Ajinomoto Health & Nutrition North America unique

  • StemFit™ gives AHN chemically defined stem-cell media for regenerative medicine workflows.
  • Raleigh QC lab upgrade on June 4, 2025 strengthened API quality and scale.
  • Ajinomoto’s amino-acid fermentation heritage anchors AHN’s formulation and manufacturing discipline.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Vacation
  • Paid Holidays
  • Parental Leave
  • Flexible Work Hours
  • Wellness Program
  • Life Insurance
  • Disability Insurance
  • Tuition Reimbursement
  • Mental Health Support

Company News

Business Wire
Jun 22nd, 2026
Syntax Bio, Ajinomoto Health & Nutrition North America, Inc. collaborate to evaluate stem cell culture technologies using Cellgorithm(TM) platform.

Syntax Bio, Ajinomoto Health & Nutrition North America, Inc. collaborate to evaluate stem cell culture technologies using Cellgorithm(TM) platform. The collaboration will evaluate Ajinomoto Group's stem cell culture products using Syntax Bio's programmable stem cell differentiation platform to support improved regenerative medicine discovery, development, and manufacturing. CHICAGO & ITASCA, Ill.-(BUSINESS WIRE)-Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture innovation and part of Ajinomoto Group, today announced a collaboration to evaluate Ajinomoto Group's StemFit(TM) stem cell culture products using Syntax Bio's proprietary Cellgorithm(TM) platform. Syntax Bio and Ajinomoto Health & Nutrition North America are collaborating to evaluate stem cell culture technologies that could enhance the performance, consistency and scalability of regenerative medicine discovery, development and manufacturing. Share Through the collaboration, AHN is providing Syntax Bio with StemFit(TM) stem cell culture media products to demonstrate Cellgorithm(TM) compatibility, performance and workflow optimization. Syntax Bio will evaluate StemFit(TM) and generate data to support their growing pipeline of cell therapy collaborations. "We are excited to support Syntax Bio's innovative approach to stem cell differentiation," said Michael Lish, President & CEO of Ajinomoto Health & Nutrition North America, Inc. "StemFit(TM) provides a highly controlled and reliable culture environment that is well-suited to complement advanced platforms like Cellgorithm(TM). By supporting a smooth transition from research workflows and potentially toward manufacturing applications, we believe our solutions can help accelerate the development of next-generation cell therapies." "The development of cell therapies depends on having compatible and reproducible technologies across every stage of the workflow, including the environments used to grow and maintain cells," said John Craighead, Ph.D., CEO of Syntax Bio. "Collaborating with Ajinomoto Group gives us the opportunity to evaluate high-performance stem cell culture products using our Cellgorithm(TM) platform to enhance efficiency, consistency, and scale across many regenerative medicine applications." Cellgorithm(TM) technology simplifies stem cell differentiation by programming the sequence of gene activations needed to create specific cell types. The platform reduces the need for repeated manual interventions and has demonstrated the ability to generate target cell types in days or weeks rather than months. Through collaborations with innovators such as Syntax Bio, Ajinomoto Group aims to explore expanding the use of StemFit(TM) into more advanced cell development and potential future manufacturing processes. This initiative supports the company's broader goal of advancing regenerative medicine with high-quality solutions that improve reliability, safety, and scalability across cell therapy development and production. About Syntax Bio Syntax Bio is a synthetic biology company programming the next generation of cell therapies. Its proprietary Cellgorithm(TM) platform uses a CRISPR-based system to program and accelerate stem cell differentiation, transforming how regenerative medicines are discovered, developed, and manufactured. By replacing slow, labor-intensive differentiation processes with a rapid, programmable approach that mimics human development, Syntax Bio makes cellular generation more reliable and scalable at unprecedented speed, unlocking new possibilities across the biotechnology industry. Learn more at www.syntaxbio.com. About Ajinomoto Health & Nutrition North America, Inc. Ajinomoto Health & Nutrition North America, Inc. is a wholly-owned subsidiary of Ajinomoto Group, a global leader in amino acid science and the research, development, manufacture, and sale of amino acid-based products across pharmaceutical, nutraceutical, sports nutrition, health and beauty, and food industries. Building on its long-standing expertise in amino acid technologies, the company is advancing regenerative medicine by providing high-quality, chemically defined stem cell culture media, including the StemFit(TM) series, which supports the development of safe, reliable, and scalable cell therapies. For additional information, please visit www.ajihealthandnutrition.com. Contacts. Ajinomoto Health & Nutrition North America, Inc. Kimberly Kennedy [email protected] More News From Syntax Bio CHICAGO-( BUSINESS WIRE )-Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of directors and scientific advisory board. The expansion brings Syntax Bio's Series A to $14.4 million and total funding to over $25 million. The expanded round builds on support from Astellas Venture Management, Illumina Ventures, DCVC Bio, Civilization Ventures, EGB Capital, Mansu... CHICAGO-( BUSINESS WIRE )-Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on advancing stem cell-derived pancreatic cell therapies for type 1 diabetes. Under the collaboration, the teams seek to define and develop an allogeneic pancreatic beta cell therapy for insulin-dependent diabetes based on patient needs. Syntax Bio plans to use its proprietary CellgorithmTM platform to gui... CHICAGO & NEW YORK-( BUSINESS WIRE )-Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced it has received an award of up to $856,250 from Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, under its Industry Discovery and Development Partnership (IDDP) program to advance a pancreatic beta cell therapy targeting T1D using its Cellgorithm platform technology. "The daily burden for those living with t...

PR Newswire
Jun 4th, 2025
Ajinomoto Health Nutrition North America, Inc. Opens Quality Control Laboratory Following $2.1M Renovation

RALEIGH, N.C., June 4, 2025 /PRNewswire/ -- Ajinomoto Health & Nutrition North America, Inc. (AHN), a global leader in amino acid manufacturing, celebrated the opening of its renovated Quality Control Laboratory today with a ribbon-cutting ceremony.Global senior leaders and dedicated team members who have been integral to the renovation efforts gathered at the modern facility on AHN's Raleigh, North Carolina, campus. The re-envisioned lab showcases AHN's commitment to delivering top product quality and leading safety standards."By updating our facilities, we are even more equipped to meet the evolving needs of our customers and maintain our position as a leader in the industry," said Jessica Lee, Quality Manager. "Our Quality Control Laboratory is part of Ajinomoto Health and Nutrition's ongoing investment in quality and innovation."With the expanding need for amino acids in today's market, AHN's Quality Control Laboratory features advanced analytical equipment, improved workflow efficiencies, and enhanced safety measures. The facility benefits from Raleigh's skilled workforce, top universities, and numerous life sciences support companies, strengthening the area's reputation as a leading biotech hub.The enhancements also support AHN's growth plan for supplying Active Pharmaceutical Ingredient (API) amino acids and blends globally.By investing in these upgrades, AHN is positioning itself to meet the increasing global demand for high-quality APIs. The improved laboratory enables AHN to scale production and maintain stringent quality standards across larger volumes

PR Newswire
Feb 11th, 2025
Ajinomoto Co., Inc., Through Its Subsidiary Ajinomoto Health Nutrition North America, Inc., Announces Gold Sponsorship Of Labcentral: Accelerating Innovation In Biotechnology

CAMBRIDGE, Mass., Feb. 11, 2025 /PRNewswire/ -- Ajinomoto Co., Inc., a global leader in biotechnology and food innovation, proudly announces its sponsorship of LabCentral, a premier launchpad for high-potential life sciences and biotech startups located in the heart of the Greater Boston biotechnology community. This partnership underscores the Ajinomoto Group's commitment to fostering innovation, collaboration, and scientific advancement in this rapidly evolving sector and thriving ecosystem.The sponsorship is in full alignment with the Ajinomoto Group's purpose to contribute to the well-being of all human beings, our society, and our planet with "AminoScience" and its cutting-edge technologies, including innovations in cell and gene therapy, amino acid, and protein sciences. The Ajinomoto Innovation Strategy Development Team in particular is fully committed to supporting the thriving biotech ecosystem in Cambridge and Massachusetts.LabCentral, located in Cambridge, provides startups with the laboratory space, resources, and community necessary to translate breakthrough ideas into viable solutions. The Ajinomoto Group's sponsorship will enhance LabCentral's ability to support promising ventures in areas such as drug discovery, cell and gene therapy, and other transformative life sciences fields."LabCentral represents the nexus of innovation and opportunity in biotech, and the Ajinomoto Group is honored to support its mission of empowering next-generation startups," said Dr. Ikuo Kira, Executive Officer & Vice President, General Manager, North America Division

AgFunder
Jul 31st, 2024
Shiru And Ajinomoto Team Up On Ai-Powered Sweet Protein Discovery Journey

Protein discovery startup Shiru has teamed up with Ajinomoto Health Nutrition Partners, part of ingredients giant Ajinomoto, to develop and commercialize sweet proteins: high intensity natural sweeteners that can replace sugar in beverages and other products. Natural sweeteners such as stevia and monk fruit have improved significantly in recent years. However, sweet proteins—which are found in fruits and berries that grow near the equator and can be up to 5,000x sweeter than sugar with no impact on blood glucose—add an exciting new dimension to the natural sugar-reduction toolbox, Shiru founder and CEO Dr. Jasmin Hume told AgFunderNews. The challenge, she says, has been two-fold. First, identifying proteins in nature with the right kind of sweetness (without linger, stability issues, etc)

vegconom GmbH
Jul 31st, 2024
Shiru and Ajinomoto Health & Nutrition Partner to Develop Sweet Proteins That Can Replace Sugar

Shiru and Ajinomoto Health & Nutrition partner to develop sweet proteins that can replace sugar.